Jo Bhakdi

Member Since 2022

Jo Bhakdi

Founder and CEO

Quantgene

California

Jo Bhakdi is the Founder and CEO of Quantgene with the mission to extend the healthy human life span by a decade within a decade. Together with Quantgene’s team of scientists and engineers, he is dedicated to introducing cloud, AI and precision diagnostics into the standard of care to enhance quality and accessibility of care for everyone and protect human life. Born to scientist parents, Jo grew up with a backdrop of medical research before earning a Master’s in Economics from Tubingen University, one of Germany’s leading academic institutions. Prior to Quantgene, Jo held executive positions at BDDO and Omnicom with a focus on business model innovation and technology, then founded i2X, an investment platform that provides quantitative analytics for biotechnology and technology portfolios.

SKILLS

  • Biotechnology
  • Business Strategy
  • Entrepreneurship

RECENT CONTENT

April 4th, 2023

Why Wellness Shouldn't Be A Trend

I believe (and science demonstrates) that the most effective health interventions are developed over a lifetime, through an individualized approach. This means we need new wellness goals altogether. 

COMPANY INFO

Quantgene

Quantgene was founded in 2015 at UC Berkeley with the mission to detect cancer and other diseases early and protect human life. Now based in Santa Monica, CA, with offices in Portland and Berlin, Quantgene has galvanized a team of scientists and technologists to push the boundaries of precision and preventive medicine. With the backbone of a world-leading laboratory infrastructure and AI-powered cloud system, Quantgene has utilized its talent and technology to transform healthcare through three business units: Apollo, Pandemic Protect, and Serenity. Apollo deploys the world’s most advanced medical intelligence system to close the care gap in precision preventive medicine and chronic care management for providers and large systems. Pandemic Protect has kept Hollywood’s entertainment industry in business and has partnered with government agencies coast-to-coast, keeping US citizens safe. Using superior data and intelligence to detect genetic and real-time medical risks, Serenity aims to extend the healthy human lifespan by a decade within a decade.

AREA OF FOCUS

  • Health Diagnostics
  • Artificial Intelligence
  • Health Care

INDUSTRY

Technology

© 2023 Newsweek Forum, LLC. All rights reserved. | Terms and Conditions and Privacy Policy | Newsweek® and the other denoted terms and the related trade dress are a non-exclusive list of the trademarks of Newsweek, LLC. in the U.S. and/or other countries. Newsweek, LLC trademarks and trade dress may not be used in connection with any product or service that is not Newsweek, LLC, in any manner that is likely to cause confusion among customers, or any manner that disparages Newsweek, LLC. This site contains the trademarks, service marks, and logos of third parties and such trademarks and service marks are the property of their respective owners and not owned by Newsweek, LLC. Such third party trademark owners may or may not be affiliated with, connected to, or sponsored by Newsweek, LLC. These third party marks include but are not limited to Newsweek®, which is a registered trademark of and the property of Newsweek, LLC.